Table of Contents
ISRN Endocrinology
Volume 2011 (2011), Article ID 219494, 4 pages
http://dx.doi.org/10.5402/2011/219494
Case Report

Results of the Prolonged Use of Subcutaneous Continuous Infusion of Hydrocortisone in a Man with Congenital Adrenal Hyperplasia

Service d'Endocrinologie, Hôpital de la Cavale Blanche CHU de Brest, Boulevard Tanguy Prigent, 29609 Brest Cedex, France

Received 24 December 2010; Accepted 16 February 2011

Academic Editors: M. De Rosa, J. A. Rillema, and J. W. Tomlinson

Copyright © 2011 Emmanuel Sonnet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. C. White and P. W. Speiser, “Congenital adrenal hyperplasia due to 21-hydroxylase deficiency,” Endocrine Reviews, vol. 21, no. 3, pp. 245–291, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. J. P. Bercovici, J. Fiet, L. Gibault et al., “Testicular adrenal rest tumours in salt wasting congenital adrenal hyperplasia (in vivo and in vitro studies),” Journal of Steroid Biochemistry and Molecular Biology, vol. 93, no. 1, pp. 67–72, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. N. M. M. L. Stikkelbroeck, B. J. Otten, A. Pasic et al., “High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 12, pp. 5721–5728, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Reisch, L. Flade, M. Scherr et al., “High prevalence of reduced fecundity in men with congenital adrenal hyperplasia,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 5, pp. 1665–1670, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. H. L. Claahsen-van der Grinten, B. J. Otten, F. C. Sweep, and A. R. Hermus, “Repeated successful induction of fertility after replacing hydrocortisone with dexamethazone in a patient with congenital adrenal hyperplasia and testicular adrenal rest tumors,” Fertility and Sterility, vol. 88, pp. 705e5–705e8, 2007. View at Google Scholar
  6. K. Lovas and E. S. Husebye, “Continuous subcutaneous hydrocortisone infusion in Addison’s disease,” European Journal of Endocrinology, vol. 157, pp. 109–112, 2007. View at Google Scholar
  7. Z. Merza, A. Rostami-Hodjegan, A. Memmott et al., “Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia,” Clinical Endocrinology, vol. 65, no. 1, pp. 45–50, 2006. View at Publisher · View at Google Scholar · View at PubMed
  8. S. M. Bryan, J. W. Honour, and P. C. Hindmarsh, “Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion,” Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 9, pp. 3477–3480, 2009. View at Publisher · View at Google Scholar · View at PubMed
  9. J. Newell-Price, M. Whiteman, A. Rostami-Hodjegan et al., “Modified-released hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers,” Clinical Endocrinology, vol. 68, pp. 130–135, 2008. View at Google Scholar
  10. N. M. M. L. Stikkelbroeck, B. J. Otten, A. Pasic et al., “High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia,” Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 12, pp. 5721–5728, 2001. View at Publisher · View at Google Scholar
  11. H. L. Claahsen-van der Grinten, B. J. Otten, M. M. L. Stikkelbroeck, F. C. G. J. Sweep, and A. R. M. M. Hermus, “Testicular adrenal rest tumours in congenital adrenal hyperplasia,” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 23, no. 2, pp. 209–220, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. K. Løvås, J. H. Loge, and E. S. Husebye, “Subjective health status in Norwegian patients with Addison's disease,” Clinical Endocrinology, vol. 56, no. 5, pp. 581–588, 2002. View at Publisher · View at Google Scholar
  13. M. Riedel, A. Wiese, T. H. Schurmeyer, and G. Brabant, “Quality of life in patients with Addison's disease: effects of different cortisol replacement modes,” Experimental and Clinical Endocrinology, vol. 101, no. 2, pp. 106–111, 1993. View at Google Scholar · View at Scopus
  14. A. Bachelot, G. Plu-Bureau, E. Thibaud et al., “Long-term outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency,” Hormone Research, vol. 67, no. 6, pp. 268–276, 2007. View at Publisher · View at Google Scholar · View at PubMed